View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

OPM RIN: 3206-AO27 Publication ID: Spring 2022 
Title: Prescription Drug and Health Care Spending 

This rule implements the prescription drug reporting requirements that apply to group health plans, and health insurance issuers offering coverage in the group and individual markets under section 204 of title II of Division BB of the Consolidated Appropriations Act.

Agency: Office of Personnel Management(OPM)  Priority: Economically Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: Undetermined  Unfunded Mandates: No 
CFR Citation: 5 CFR 890   
Legal Authority: Pub. L. 116-260, Division BB, title I and title II   
Legal Deadline:  None
Action Date FR Cite
Request for Information  06/23/2021  86 FR 32813   
Request for Information Comment Period End  07/23/2021 
Interim Final Rule  11/23/2021  86 FR 66662   
Interim Final Rule Effective  12/23/2021 
Interim Final Rule Comment Period End  01/24/2022 
Analyze Comments  06/00/2022 
Final Action  11/00/2024 
Regulatory Flexibility Analysis Required: Undetermined  Government Levels Affected: Local, State 
Small Entities Affected: No  Federalism: Yes 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Related RINs: Related to 0938-AU66  Related Agencies: Joint: HHS; 
Agency Contact:
Padma Babubhai Shah
Senior Policy Analyst
Office of Personnel Management
1900 E Street NW,
Washington, DC 20415
Phone:202 606-4056